Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pike

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
Urology|September 17, 2022
Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage RadiationBrandon S Imber, Elisabeth O'Dwyer, Stephanie Lobaugh, et al.
Advances in Radiation Oncology|March 17, 2025
Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate TherapyEmily S Lebow, Jordan Eichholz, Zhigang Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation TherapyAndrew Bang, Tyler J Wilhite, Luke R G Pike, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-lifeKurt G Pike, Joanne V Allen, Peter W R Caulkett, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
Design of a potent, soluble glucokinase activator with excellent in vivo efficacyDarren McKerrecher, Joanne V Allen, Peter W R Caulkett, et al.
Journal of Medicinal Chemistry|June 4, 2016
Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) KinaseSébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Journal of Medicinal Chemistry|July 4, 2018
Correction to Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) KinaseSébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Plos One|October 27, 2021
Revisiting the Middle and Upper Palaeolithic archaeology of Gruta do Caldeirão (Tomar, Portugal)João Zilhão, Diego E Angelucci, Lee J Arnold, et al.
Journal of Neuro-Oncology|November 11, 2025
Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosisAllison J Toth, Stephanie M Robert, Tara Fahy, et al.
Molecular Genetics and Metabolism|March 16, 2010
Multiplex ligation-dependent probe amplification (MLPA) analysis is an effective tool for the detection of novel intragenic PLA2G6 mutations: implications for molecular diagnosisDanielle Crompton, Pauline K Rehal, Lesley MacPherson, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
Urology|September 17, 2022
Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage RadiationBrandon S Imber, Elisabeth O'Dwyer, Stephanie Lobaugh, et al.
Advances in Radiation Oncology|March 17, 2025
Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate TherapyEmily S Lebow, Jordan Eichholz, Zhigang Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation TherapyAndrew Bang, Tyler J Wilhite, Luke R G Pike, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-lifeKurt G Pike, Joanne V Allen, Peter W R Caulkett, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
Design of a potent, soluble glucokinase activator with excellent in vivo efficacyDarren McKerrecher, Joanne V Allen, Peter W R Caulkett, et al.
Journal of Medicinal Chemistry|June 4, 2016
Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) KinaseSébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Journal of Medicinal Chemistry|July 4, 2018
Correction to Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) KinaseSébastien L Degorce, Bernard Barlaam, Elaine Cadogan, et al.
Plos One|October 27, 2021
Revisiting the Middle and Upper Palaeolithic archaeology of Gruta do Caldeirão (Tomar, Portugal)João Zilhão, Diego E Angelucci, Lee J Arnold, et al.
Journal of Neuro-Oncology|November 11, 2025
Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosisAllison J Toth, Stephanie M Robert, Tara Fahy, et al.
Molecular Genetics and Metabolism|March 16, 2010
Multiplex ligation-dependent probe amplification (MLPA) analysis is an effective tool for the detection of novel intragenic PLA2G6 mutations: implications for molecular diagnosisDanielle Crompton, Pauline K Rehal, Lesley MacPherson, et al.
Pageof 20